NCT05227326View on ClinicalTrials.gov

AOH1996 for the Treatment of Refractory Solid Tumors

PHASE1RecruitingINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

August 12, 2022

Primary Completion Date

September 13, 2029

Study Completion Date

September 13, 2029

Conditions
Refractory Malignant Solid NeoplasmOsteosarcomaLeiomyosarcomasSynovial SarcomasOvarian CancerNon-Small Cell Lung CancerPancreatic Cancer
Interventions
DRUG

PCNA Inhibitor AOH1996

Given PO

Trial Locations (2)

85258

NOT_YET_RECRUITING

Honor Health Research and Innovation Institute, Scottsdale

91010

RECRUITING

City of Hope Medical Center, Duarte

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

City of Hope Medical Center

OTHER